GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models ; volume:66 ; number:7 ; day:30 ; month:3 ; year:2023 ; pages:1306-1321 ; date:7.2023
Diabetologia ; 66, Heft 7 (30.3.2023), 1306-1321, 7.2023
- Urheber
-
Gorgogietas, Vyron
Rajaei, Bahareh
Heeyoung, Chae
Santacreu, Bruno J.
Marín-Cañas, Sandra
Salpea, Paraskevi
Sawatani, Toshiaki
Musuaya, Anyishai
Arroyo, María N.
Moreno-Castro, Cristina
Benabdallah, Khadija
Demarez, Celine
Toivonen, Sanna
Cosentino, Cristina
Pachera, Nathalie
Lytrivi, Maria
Cai, Ying
Carnel, Lode
Brown, Cris
Urano, Fumihiko
Marchetti, Piero
Gilon, Patrick
Eizirik, Decio L.
Cnop, Miriam
Igoillo-Esteve, Mariana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-05905-8
- URN
-
urn:nbn:de:101:1-2023091516273266858285
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gorgogietas, Vyron
- Rajaei, Bahareh
- Heeyoung, Chae
- Santacreu, Bruno J.
- Marín-Cañas, Sandra
- Salpea, Paraskevi
- Sawatani, Toshiaki
- Musuaya, Anyishai
- Arroyo, María N.
- Moreno-Castro, Cristina
- Benabdallah, Khadija
- Demarez, Celine
- Toivonen, Sanna
- Cosentino, Cristina
- Pachera, Nathalie
- Lytrivi, Maria
- Cai, Ying
- Carnel, Lode
- Brown, Cris
- Urano, Fumihiko
- Marchetti, Piero
- Gilon, Patrick
- Eizirik, Decio L.
- Cnop, Miriam
- Igoillo-Esteve, Mariana
- SpringerLink (Online service)
Ähnliche Objekte (12)
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy